The Commerce Department and the International Trade Commission published the following Federal Register notices Sept. 18 on AD/CVD proceedings:
The Commerce Department published notices in the Federal Register Sept. 18 on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms or effective dates will be detailed in another ITT article):
The Commerce Department intends to create another new exemption for off-grid panels from antidumping and countervailing duties on crystalline silicon photovoltaic cells, whether or not assembled into modules, from China (A-570-979/C-570-980), it said in the preliminary results of a changed circumstances review published Sept. 18. Commerce said “substantially all” U.S. producers of solar cells, including original petitioner American Alliance for Solar Manufacturing, don't oppose Source Global's request to create the exemption. Should Commerce finalize this determination in its final results, it will exempt the following products from the scope of AD/CVD on solar cells:
The Commerce Department made several errors in its handling of the resumption of an antidumping duty investigation on tomatoes from Mexico after the termination of a suspension agreement, Mexican tomato exporter Bioparques de Occidente said in a Sept. 13 reply brief at the Court of International Trade (Bioparques de Occidente v. U.S., CIT # 19-00204).
U.S. District Judge Beth Labson Freeman for Northern California in San Jose granted NetChoice’s motion for a preliminary injunction blocking California Attorney General Rob Bonta (D) from enforcing the state’s Age Appropriate Design Code (AB-2273), finding that California hasn't shown that the challenged statute "passes constitutional muster," said her signed order Monday (docket 5:22-cv-08861).
The International Trade Commission published notices in the Sept. 15 Federal Register on the following AD/CVD injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The Commerce Department will recognize a name change for a South Korean company for the purposes of antidumping duties on dioctyl terephthalate (A-580-889) from South Korea, upholding its preliminary finding in the final results of a changed circumstances review. The agency found Aekyung Chemical Co., Ltd., to be the successor-in-interest to Aekyung Petrochemical Co., Ltd. The agency found that Aekyung Chemical continues to operate as the same business entity other than the change in name. Commerce said Aekyung Chemical will inherit the AD cash deposit rate assigned to Aekyung Petrochemical, currently zero percent, for subject merchandise.
AT&T told the FCC it tested a signal booster allegedly causing interference with operations in 2.3 GHz spectrum and found that, despite the assurances of the company that makes the device, it's active in the wireless communications service band (see 2308280048). The booster is made by Shen Zhen Anntlent Communication Technology, marketed in the U.S. under the Phonetone and Anntlent brand names. The Chinese company told AT&T WCS operations had been turned off, said a filing posted Thursday in docket 10-4. “Preliminary testing suggests that, contrary to the FCC’s rules and Grantee’s on-the-record assertions, this device -- advertised and marketed as a FCC-compliant Consumer Signal Booster -- amplifies the WCS band,” AT&T said: “AT&T carefully calibrates and coordinates its WCS deployments to prevent harmful interference to third parties. If this booster -- or others like it -- are allowed to be sold and operated in the U.S., management of interference in the 2.3 GHz band will become an even greater challenge.” AT&T said it plans lab tests. The booster maker didn’t comment.
The Commerce Department and the International Trade Commission published the following Federal Register notices Sept. 15 on AD/CVD proceedings:
The Court of International Trade should sustain the Commerce Department's remand results in an antidumping duty case on xanthan gum from China, DOJ argued in its Sept. 12 response at the Court of International Trade. In June, Commerce stuck by its decisions to apply adverse facts available to Meihua, not to rescind its review of Deosen Biochemical, and not to recalculate a separate rate, in spite of a court order to reconsider all three (see 2306280043) (Meihua Group International (Hong Kong) v. U.S., CIT # 22-00069).